<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Frostbite: Emergency care and prevention</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Frostbite: Emergency care and prevention</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Frostbite: Emergency care and prevention</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ken Zafren, MD, FAAEM, FACEP, FAWM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">C Crawford Mechem, MD, FACEP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel F Danzl, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 26, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Frostbite results from the freezing of tissue. It is a disease of morbidity, not mortality. It is most frequently encountered in mountaineers and other cold weather enthusiasts, soldiers, those who work in the cold, the homeless, and individuals stranded outdoors in the winter [<a href="#rid1">1-4</a>]. Among patients with severe frostbite, timely diagnosis and treatment is essential to maximize tissue salvage. </p><p>This topic review will discuss the classification, presentation, diagnosis, and management of frostbite. Severe hypothermia, high altitude illness, and other related illnesses are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/178.html" rel="external">"Accidental hypothermia in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/181.html" rel="external">"High-altitude illness: Physiology, risk factors, and general prevention"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/182.html" rel="external">"Acute mountain sickness and high-altitude cerebral edema"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/183.html" rel="external">"High-altitude pulmonary edema"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6590.html" rel="external">"High-altitude disease: Unique pediatric considerations"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>Frostbite is a severe, localized cold-induced injury due to freezing of tissue. Immersion foot (also referred to as trench foot) is a nonfreezing cold injury (NFCI) that may also cause tissue loss and long-term sequelae. Milder forms of injury include frostnip and pernio:</p><p class="bulletIndent1"><span class="glyph">●</span>Frostnip refers to cold-induced, localized paresthesias that resolve with rewarming. There is no permanent tissue damage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pernio, or chilblains, is characterized by localized inflammatory lesions that can result from acute or repetitive exposure to damp cold above the freezing point. Lesions are edematous, often reddish or purple, and may be very painful or pruritic (<a class="graphic graphic_picture graphicRef101018" href="/z/d/graphic/101018.html" rel="external">picture 1</a>). Pernio is most common in young women, but both sexes and all age ranges may be affected [<a href="#rid5">5</a>]. Permanent damage from pernio is uncommon, with symptoms and signs generally resolving within two to three weeks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immersion foot (or trench foot) involves injury to the sympathetic nerves and vasculature of the feet. It was first described in 1914 during World War I trench warfare. It results from prolonged exposure of the feet to a combination of dampness and cold. Tight-fitting boots exacerbate the condition. Feet and occasionally hands are red, edematous, can be numb or extremely painful, and, in severe cases, can be covered with hemorrhagic bullae (<a class="graphic graphic_picture graphicRef101027" href="/z/d/graphic/101027.html" rel="external">picture 2</a>). Tissue loss can occur. (See  <a class="medical medical_review" href="/z/d/html/13789.html" rel="external">"Nonfreezing cold water (trench foot) and warm water immersion injuries"</a>.)</p><p></p><p class="bulletIndent1">Improved foot hygiene including better boot design and frequent sock changes resulted in a much lower prevalence among soldiers by 1917. Not just of historical significance, immersion foot was a major medical issue during the Falklands War of 1982 and still occurs, especially among the homeless [<a href="#rid6">6,7</a>].</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>The tissue destruction of frostbite is due to both immediate cold-induced cell death and the more gradual development of reperfusion-related localized inflammatory processes and tissue ischemia. Following exposure to subfreezing temperatures, ice crystals form extracellularly. If freezing is rapid, ice crystals may also form inside cells. Fluid and electrolyte fluxes cause lysis of cell membranes with subsequent cell death. An inflammatory process ensues mediated by thromboxane A2, prostaglandin F2-alpha, bradykinins, and histamine. This leads to tissue ischemia and necrosis. The initial cellular damage and the subsequent inflammatory processes are made worse in the setting of thawing followed by refreezing of the affected area [<a href="#rid3">3,8</a>].</p><p class="headingAnchor" id="H4"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>A number of systems to classify frostbite have been developed based on initial clinical presentation, findings on scintigraphy with technetium-99m pertechnetate, and outcome [<a href="#rid3">3,9-11</a>].</p><p>One classification scheme categorizes frostbite injuries as superficial or deep. As described below, superficial frostbite corresponds to first and second-degree injury, while deep frostbite corresponds to third and fourth-degree injury [<a href="#rid12">12,13</a>].</p><p>A more useful clinical prediction tool has been developed for frostbite of the hands and feet, based on the level at which skin lesions are noted after rapid rewarming in warm water. The categories are as follow (<a class="graphic graphic_table graphicRef111122" href="/z/d/graphic/111122.html" rel="external">table 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Grade 1 frostbite is characterized by no cyanosis on the extremity (<a class="graphic graphic_picture graphicRef111118" href="/z/d/graphic/111118.html" rel="external">picture 3</a>). This predicts no amputation and no sequelae.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Grade 2 involves cyanosis isolated to the distal phalanx (<a class="graphic graphic_picture graphicRef111119" href="/z/d/graphic/111119.html" rel="external">picture 4</a>). This predicts only soft tissue amputation and fingernail or toenail sequelae.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Grade 3 frostbite is characterized by intermediate and proximal phalangeal cyanosis (<a class="graphic graphic_picture graphicRef111120" href="/z/d/graphic/111120.html" rel="external">picture 5</a>). This predicts bone amputation of the digit and functional sequelae.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Grade 4 frostbite involves cyanosis over the carpal or tarsal bones (<a class="graphic graphic_picture graphicRef111121" href="/z/d/graphic/111121.html" rel="external">picture 6</a>). This predicts bone amputation of the limb with functional sequelae [<a href="#rid10">10</a>].</p><p></p><p>The traditional classification system divides frostbite into four degrees of severity based upon the depth of tissue involvement, in similar fashion to the classification of burns:</p><p class="bulletIndent1"><span class="glyph">●</span>First-degree frostbite is very superficial and is characterized by a central area of pallor and anesthesia of the skin surrounded by edema.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Second-degree frostbite is recognized by large blisters containing clear fluid surrounded by edema and erythema, developing within 24 hours and extending to or nearly to the tips of digits (<a class="graphic graphic_picture graphicRef101059" href="/z/d/graphic/101059.html" rel="external">picture 7</a>). The blisters may form an eschar, but this later sloughs off, revealing healthy granulation tissue. There is no tissue loss.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Third-degree frostbite differs from second-degree in that the injury is deeper and the blisters are smaller, hemorrhagic and more proximal. The skin forms a black eschar in one to several weeks (<a class="graphic graphic_picture graphicRef101022" href="/z/d/graphic/101022.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef101023" href="/z/d/graphic/101023.html" rel="external">picture 9</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fourth-degree frostbite, which extends to muscle and bone, involves complete tissue necrosis. Mummification occurs in 4 to 10 days.</p><p></p><p>This traditional system gives clinicians a false sense of accuracy. It has caused many to treat frostbite injuries as if they were burns, with suboptimal results. Depending upon rewarming methods and complications, such as infection or trauma, first and second-degree frostbite can unexpectedly become third or fourth-degree.</p><p>The Hennepin Score, patterned after total body surface scoring systems for thermal burns, is used for research purposes to describe the extent of tissue involved and quantify tissue salvage rates [<a href="#rid14">14</a>]. It is not a clinical tool.</p><p class="headingAnchor" id="H5"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Frostbite generally develops within minutes to hours depending on circumstances and risk factors. Risk factors for developing frostbite and cold-induced injury include any condition that increases localized heat loss or decreases heat production. Examples include increased convective heat loss due to exposure to wind or conductive heat loss due to contact with metal, the ground, or water [<a href="#rid15">15</a>]. Exhaustion, dehydration, malnutrition, or comorbidities such as peripheral vascular disease, diabetes, or mental illness may limit an individual's ability to respond to a cold stress. Alcohol abuse predisposes to frostbite as a result of acute behavioral changes, increased heat loss from vasodilation, and chronic complications of alcohol consumption [<a href="#rid16">16</a>]. Other sedating or judgment-impairing drugs or medications pose a similar risk. Clearly, risk is greater at low ambient temperatures, when wind chill effects are increased, and at higher altitudes [<a href="#rid4">4,16-20</a>].</p><p>Additional risk factors for developing frostbite include smoking, previous cold injury, and exposure of the hands and arms to vibration, which can elicit a Raynaud phenomenon associated with white fingers in some individuals [<a href="#rid21">21-23</a>]. Data from the United States Armed Forces suggest that soldiers who are African-American, female, or younger than 20 years of age are at increased risk [<a href="#rid24">24</a>].</p><p>Use of clothing that provides inadequate insulation or coverage, or is damp, too tight, or permeable to wind, can predispose to frostbite, as can use of protective ointments, such as on the face. Studies from Norway in the 1990s showed that ointment use can enhance heat loss in some people and can provide users with a false sense of security, causing them to neglect standard safety measures [<a href="#rid25">25-27</a>]. Excessive sweating of the hands and feet increases an individual's risk of frostbite to those areas, illustrating the importance of clothing that can wick moisture away from the skin [<a href="#rid28">28</a>].</p><p>While generally considered a disease associated with environmental exposure to cold, frostbite has also been reported following direct exposure to freezing materials. As an example, the application of ice packs to reduce swelling from musculoskeletal injuries can cause frostbite [<a href="#rid29">29</a>]. It is important to tell patients to interpose a cloth between the ice pack and their skin, and to limit treatment intervals to 20 minutes with a minute or two break between applications. Fingertip contact with a metal surface at a temp of -15°C (5°F) can lead to frostbite within a few seconds [<a href="#rid15">15</a>]. </p><p>Case reports describe severe facial, upper airway, and esophageal frostbite from recreational inhalation of halogenated hydrocarbons and <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">nitrous oxide</a> [<a href="#rid30">30</a>]. Contact with Freon, a fluorinated hydrocarbon used as a refrigerant, has been reported to cause third and fourth-degree frostbite of the hand [<a href="#rid31">31-33</a>]. Frostbite of the foot has been described resulting from the discharge of a carbon dioxide fire extinguisher on a sprained ankle in an attempt to reduce edema [<a href="#rid34">34</a>]. Abdominal wall cryolipolysis can cause full thickness tissue loss, likely by frostbite combined with pressure necrosis [<a href="#rid35">35,36</a>].</p><p>Some researchers hypothesize that individual variation in cold-induced vasodilation (CIVD) corresponds to the risk of frostbite. The results of one observational study of the Royal Netherlands Navy during arctic training suggested that faster and greater CIVD may decrease risk [<a href="#rid37">37</a>], but subsequent studies have shown no correlation [<a href="#rid38">38,39</a>].</p><p class="headingAnchor" id="H6"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Because there is no formal reporting system for cases of frostbite, data on incidence and prevalence are derived from selected subpopulations, generally consisting of individuals at greater than average risk [<a href="#rid22">22,28,40</a>]. Based upon such studies, the areas of the body most susceptible to frostbite appear to be the hands, feet, face (including nose and cheeks), and ears.</p><p class="headingAnchor" id="H7"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Areas most frequently affected by frostbite include the ears, nose, cheeks, chin, fingers, and toes (<a class="graphic graphic_picture graphicRef101058" href="/z/d/graphic/101058.html" rel="external">picture 10</a> and <a class="graphic graphic_picture graphicRef101026" href="/z/d/graphic/101026.html" rel="external">picture 11</a>). Frostbite of the cornea has been reported in individuals who keep their eyes open against very strong winds [<a href="#rid7">7,41</a>]. Patients often complain of cold, numbness, and clumsiness of the affected area [<a href="#rid42">42</a>]. Before rewarming, the skin is insensate, white or grayish-yellow in color, and hard or waxy to touch (<a class="graphic graphic_picture graphicRef101025" href="/z/d/graphic/101025.html" rel="external">picture 12</a> and <a class="graphic graphic_picture graphicRef101024" href="/z/d/graphic/101024.html" rel="external">picture 13</a>). Early signs of frostbite may be less conspicuous in patients with darker skin tones. As noted above, bullae containing clear or bloody fluid may develop after thawing (<a class="graphic graphic_picture graphicRef101059" href="/z/d/graphic/101059.html" rel="external">picture 7</a>), depending on the depth of the injury. In cases of delayed presentation to medical care, eschar or other signs of tissue necrosis may be observed (<a class="graphic graphic_picture graphicRef101022" href="/z/d/graphic/101022.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef101023" href="/z/d/graphic/101023.html" rel="external">picture 9</a>). Any patient with cyanosis proximal to the distal phalanx of any digit after rapid rewarming is at risk for necrosis of the affected tissue and aggressive therapy (eg, thrombolysis in suitable candidates) may be needed. (See <a class="local">'Hospital-based management'</a> below.)</p><p class="headingAnchor" id="H8"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Diagnosis is generally made on clinical grounds, based on the context of the injury, signs, and symptoms. Diagnostic studies–namely bone scanning–are helpful in determining the existence of comorbidities, the extent of frostbite injury, and prognosis. Because frostbite is a disease of morbidity, not mortality, more immediate life-threats, such as coexisting hypothermia, must be identified and addressed first. (See  <a class="medical medical_review" href="/z/d/html/178.html" rel="external">"Accidental hypothermia in adults"</a>.)</p><p class="headingAnchor" id="H317501307"><span class="h1">IMAGING STUDIES</span><span class="headingEndMark"> — </span>Radiologic studies can help to determine the extent of tissue involvement, response to therapy, and long-term tissue viability [<a href="#rid43">43</a>]. The most important study for patients with signs of or at risk for tissue necrosis from frostbite is technetium (Tc)-99m scintigraphy (ie, bone scan). The appropriate role for each modality is described below:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Plain radiographs</strong> are not useful initially except to screen for trauma-related fractures. Late (weeks to months) radiographic findings in frostbite include bony destruction and, in children, damage to growth plates [<a href="#rid8">8</a>]. Frostbite arthritis often spares the thumbs, most likely because patients wrap them within clenched fists during the exposure [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Standard or digital subtraction angiography</strong> can be used to identify patients suitable for thrombolytic therapy [<a href="#rid45">45-47</a>]. Unlike technetium-99m scintigraphy, angiography does not visualize the microcirculation soon after injury, including in bone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fluorescence microangiography</strong>, a technique that has been used to monitor wound healing, has been used to monitor progression of perfusion in frostbite [<a href="#rid48">48</a>]. A study of 104 frostbite patients, of whom 26 were evaluated with both technetium-99m scanning and microangiography, found that amputation level correlated better with microangiography than with technetium-99m scanning [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Technetium (Tc)-99m scintigraphy</strong> (ie, bone scan) can be used to identify candidates suitable for thrombolytic therapy [<a href="#rid50">50</a>]. It is also used to predict the long-term viability of affected tissue, with the goal of allowing early debridement or amputation of dead or dying areas while preserving viable tissue [<a href="#rid11">11,14,51,52</a>]. In candidates for treatment with tissue plasminogen activator (tPA), technetium scanning is used immediately after thawing. For patients who are not candidates for tPA, technetium scanning on day 2 following injury may avoid the need for the traditional several-week delay in surgical intervention while awaiting demarcation between viable and nonviable zones. Scintigraphy has also been used to monitor response to a topical therapy protocol by demonstrating the effect of treatment on involved tissue microvasculature [<a href="#rid9">9,53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Limited retrospective data suggest that <strong>single-photon emission computed tomography</strong> (SPECT), a nuclear bone scan processed similarly to a computed tomography (CT) scan, combined with conventional CT (SPECT/CT), may be able to identify non-salvageable tissue, allowing more accurate determination of the extent of tissue destruction and autoamputation than a conventional bone scan [<a href="#rid54">54</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some researchers claim that <strong>magnetic resonance imaging</strong> (MRI) and magnetic resonance angiography (MRA) may be superior to bone scans in establishing tissue viability. In case reports they have permitted visualization of occluded blood vessels and better demonstrated the line of demarcation between ischemic and nonischemic tissue. However, experience with MRI and MRA in this setting is limited [<a href="#rid8">8,55</a>].</p><p></p><p class="headingAnchor" id="H9"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment can be divided into prehospital interventions and definitive care. The approach described below is based on animal studies, observational data, clinical experience, and relatively small number of clinical trials. Management of hypothermia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/178.html" rel="external">"Accidental hypothermia in adults"</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Prehospital care</span></p><p class="bulletIndent1"><span class="glyph">●</span>Get the patient to a warm environment as soon as possible. Whenever possible, pad or splint the affected area to minimize injury en route.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Remove wet clothing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avoid walking on frostbitten feet; this can increase tissue damage. If walking is necessary for evacuation, do not rewarm the feet before walking.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not rewarm frostbitten tissue if there is a possibility of refreezing before reaching definitive care. This would result in worse tissue damage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If prehospital warming is attempted, options include placing the affected area in warm (not hot) water or warming it using body heat (eg, placing frostbitten fingers in the axillae).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Do not rub frostbitten areas in an attempt to rewarm them; this can cause further tissue damage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avoid the use of stoves or fires to rewarm frostbitten tissue. Such tissue may be insensate and burns can result [<a href="#rid8">8,41,56</a>].</p><p></p><p class="headingAnchor" id="H11"><span class="h2">Hospital-based management</span><span class="headingEndMark"> — </span>Once the patient has reached the hospital, definitive care consists of rapid rewarming, wound care, efforts to enhance tissue viability, and prevention of complications [<a href="#rid20">20,57-59</a>]. Among patients with severe frostbite, timely diagnosis and treatment is essential to maximize limb and digit salvage [<a href="#rid52">52</a>]. Management of other, more serious conditions, such as severe hypothermia or internal hemorrhage from major trauma, takes priority over the treatment of frostbite. (See  <a class="medical medical_review" href="/z/d/html/178.html" rel="external">"Accidental hypothermia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/13854.html" rel="external">"Initial management of trauma in adults"</a>.) </p><p class="headingAnchor" id="H1943419999"><span class="h3">Rewarming</span><span class="headingEndMark"> — </span>Rewarming is most effectively accomplished by immersing the affected area in water heated to 37 to 39°C (98.6 to 102.2°F), ideally in a whirlpool so a steady temperature can be maintained [<a href="#rid60">60</a>]. Gentle active motion of the extremity while rewarming may help. Care should also be taken to avoid trauma to the injured area against the container walls during treatment. Higher temperatures do not warm the injured area appreciably faster and cause the warming process to be much more painful. Dry heat is difficult to regulate and is not recommended.</p><p>Thawing is usually complete when the tissue is red or purple and soft to the touch. This usually takes 15 to 30 minutes. Rewarming of frostbitten tissue may be painful. Appropriate analgesia, generally opioids, should be administered.</p><p class="headingAnchor" id="H3398613635"><span class="h3">Time-limited treatments for severe injury</span></p><p class="headingAnchor" id="H3806635444"><span class="h4">Thrombolysis for severe injury presenting within 24 hours</span></p><p class="headingAnchor" id="H1688022047"><span class="h5">Indications and general guidance</span><span class="headingEndMark"> — </span>Because frostbite is associated with vascular thrombosis of affected tissue, administration of intravenous or intra-arterial tissue plasminogen activator (tPA; with intravenous or intra-arterial heparin, or subcutaneous <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">enoxaparin</a>) has been used for therapy [<a href="#rid45">45,50,61,62</a>]. Although high-quality evidence is limited, in patients at high risk for life-altering amputation (eg, multiple digits in a limb, multiple limbs, proximal limb amputation), <strong>without contraindications</strong> to the use of tPA, who present within 24 hours of injury, we suggest treatment with intravenous tPA plus subcutaneous low-molecular weight heparin (eg enoxaparin) or intravenous heparin. The use of intra-arterial tPA with heparin is also reasonable in facilities capable of administering intra-arterial tPA. </p><p>Hennepin County Medical Center (Minneapolis, USA) has found that treatment with intravenous tPA and subcutaneous <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">enoxaparin</a> is effective and more easily accomplished than treatment with intra-arterial tPA (see administration regimens below). Controlled trials comparing intra-arterial and intravenous tPA for the treatment of severe frostbite have not been conducted. </p><p>The American Burn Association has published guidelines for thrombolytic therapy for frostbite [<a href="#rid63">63</a>]. According to their guidelines, thrombolytic therapy may be used for patients with cyanosis proximal to the distal phalanx (grade 3 or 4 frostbite injury) and demonstrated loss of perfusion at or proximal to the middle phalanx immediately after rewarming.</p><p>Whenever possible, treatment should be performed at or in consultation with a center experienced in the use of tPA for frostbite. Patients appropriate for treatment with tPA are also appropriate for treatment with <a class="drug drug_general" data-topicid="8895" href="/z/d/drug information/8895.html" rel="external">iloprost</a>. (See <a class="local">'Prostacyclin therapy for severe injury presenting within 48 hours'</a> below.)</p><p>The degree of frostbite should be assessed using the extent of cyanosis immediately after rewarming, as described in the classification section [<a href="#rid10">10</a>]. Patients with cyanosis proximal to the interphalangeal joints should be evaluated with technetium scanning or CT angiography. If circulation is absent proximal to the interphalangeal joints, tPA should be given, unless contraindicated. (See <a class="local">'Classification'</a> above and <a class="local">'Imaging studies'</a> above.)</p><p class="headingAnchor" id="H456076116"><span class="h5">Risks and contraindications</span><span class="headingEndMark"> — </span>Thrombolysis is associated with a small but important risk of dangerous bleeding (eg, intracranial hemorrhage). Contraindications to tPA include, but are not limited to, recent stroke or persistent neurologic impairment, intracranial trauma, recent significant gastrointestinal bleeding, and recent surgery. Before administering tPA, clinicians must carefully assess the patient's risk for significant bleeding complications. Do <strong>not</strong> give tPA to patients at significant risk for such complications, which are summarized in the following table (<a class="graphic graphic_table graphicRef95035" href="/z/d/graphic/95035.html" rel="external">table 2</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/55.html" rel="external">"Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy", section on 'Contraindications'</a> and  <a class="medical medical_review" href="/z/d/html/16134.html" rel="external">"Intravenous thrombolytic therapy for acute ischemic stroke: Therapeutic use"</a>.)</p><p class="headingAnchor" id="H1227192170"><span class="h5">Administration and dosing</span><span class="headingEndMark"> — </span>There are no standardized dosing regimens for tPA in the treatment of severe frostbite injury. Reasonable approaches are described below.</p><p>As soon as angiography or technetium-99m scanning shows that there is no perfusion to the affected area(s), intravenous (IV) or intra-arterial tPA should begin as soon as possible, but no longer than 24 hours after thawing.</p><p class="bulletIndent1"><span class="glyph">●</span>For <strong>IV administration</strong> of tPA, we suggest the following regimen [<a href="#rid52">52,63,64</a>]: </p><p></p><p class="bulletIndent1">Give a bolus dose of 0.15 mg/kg over 15 minutes, followed by a continuous IV infusion of 0.15 mg/kg per hour for six hours. The maximum total dose is 100 mg.</p><p></p><p class="bulletIndent1">After tPA has been given, adjunct treatment can be started with IV heparin or subcutaneous (SC) <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">enoxaparin</a>. The dose of IV heparin is 500 to 1000 units/hour for six hours, or targeted to maintain the partial thromboplastin time (PTT) at twice the control value. Enoxaparin can be given at the therapeutic dose (1 mg/kg SC).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For <strong>intra-arterial administration</strong> of tPA, we suggest the following regimen [<a href="#rid45">45,46,65,66</a>]: </p><p></p><p class="bulletIndent1">Give a bolus of 2 to 4 mg, followed by an infusion of 0.5 to 1 mg/hour via the femoral or brachial artery. Repeat angiograms are performed every 8 to 12 hours.</p><p></p><p class="bulletIndent1">A few centers give an intra-arterial vasodilator, most commonly <a class="drug drug_general" data-topicid="9739" href="/z/d/drug information/9739.html" rel="external">papaverine</a> (150 mg), immediately before administering intra-arterial tPA [<a href="#rid54">54,67</a>]. </p><p></p><p class="bulletIndent1">If more than one extremity is affected, divide the total tPA dose between or among them. Treatment should be continued until perfusion is restored (as demonstrated by angiography or technetium-99m scanning) or a time limit of 72 hours is reached. </p><p></p><p class="bulletIndent1">Adjunct treatment with heparin can be given at 500 units/hour via the intra-arterial catheter. </p><p></p><p>Hennepin County Medical Center, a facility with extensive experience managing frostbite, uses the following thrombolytic protocol:</p><p class="bulletIndent1"><span class="glyph">●</span>Rapidly rewarm frostbitten tissue in warm (not hot) water until it can be assessed for the presence of hemorrhagic blisters or acral hypoperfusion (cyanosis). (See <a class="local">'Rewarming'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Perform a technetium-99m triple-phase bone scan. Patients expected to require significant amputations due to tissue necrosis and who have undergone rewarming within 12 hours injury, without freeze-thaw cycles (ie, repeated episodes of refreezing and thawing), are eligible for thrombolysis in the absence of contraindications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For suitable patients at risk for tissue necrosis and with no contraindications, administer a loading dose of <a class="drug drug_general" data-topicid="8478" href="/z/d/drug information/8478.html" rel="external">alteplase</a>, 0.15 mg/kg intravenously over 15 minutes. Following the loading dose, start an infusion of alteplase, 0.15 mg/kg per hour for 6 hours. (While earlier reports involved intra-arterial administration of tPA and heparin, the Hennepin experience has been that the intravenous route for tPA is also effective and more easily accomplished.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Perform another technetium-99m triple-phase bone scan to verify reperfusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After treatment with <a class="drug drug_general" data-topicid="8478" href="/z/d/drug information/8478.html" rel="external">alteplase</a> is completed, begin treatment with <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">enoxaparin</a>, 1 mg/kg subcutaneously, given twice daily for 14 days.</p><p></p><p>Clinicians must discuss the relative risks and benefits of thrombolytic treatment with the patient and obtain informed consent. Treatment with thrombolytics assumes the patient is willing to accept a small risk of potentially catastrophic bleeding in return for a greater likelihood of retaining functional digits or limbs. Rates of tissue salvage improve with decreasing time from rewarming to thrombolysis [<a href="#rid52">52</a>].</p><p>Evidence in support of thrombolytic treatment of severe frostbite is largely observational but growing [<a href="#rid62">62,64,66,68-70</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>In a systematic review, data were extracted from 16 studies and case series involving a total of 209 patients with 1109 digits at risk for amputation from frostbite and treated with thrombolytic therapy using either intra-arterial or intravenous tPA [<a href="#rid62">62</a>]. The salvage rate for digits treated with intra-arterial tPA (n = 926) was 76 percent, while the salvage rate for digits treated with intravenous tPA (n = 63) was 62 percent. Although statistical analysis was not possible due to heterogeneity among the studies, it may well be that there is no significant statistical or clinical difference in digit salvage rate between intravenous and intra-arterial tPA. Digital subtraction angiography was used for the initial evaluation in nine studies, and triple-phase bone scan was used in six. While patient characteristics and study inclusion criteria varied, the authors of the review noted that thrombolytic therapy was less effective in patients with prolonged exposure (longer than 24 hours) or freeze-thaw-refreeze injuries.  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another systematic review assessed 17 studies involving a total of 1844 limbs and digits with frostbite in 325 patients, 216 of whom were treated with thrombolysis [<a href="#rid68">68</a>]. This review included studies using a number of thrombolytic agents. While limb salvage rates varied from 0 to 100 percent among studies, the weighted average was 79 percent.</p><p></p><p>The administration of <a class="drug drug_general" data-topicid="9739" href="/z/d/drug information/9739.html" rel="external">papaverine</a>, a vasodilator, followed by tPA has been associated with good patient outcomes in case reports [<a href="#rid69">69</a>]. However, a controlled trial of tPA with and without papaverine has yet to be performed. <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">Nitroglycerin</a> has also been used as a vasodilator to facilitate treatment with intra-arterial tPA [<a href="#rid47">47</a>].</p><p class="headingAnchor" id="H1902794625"><span class="h4">Prostacyclin therapy for severe injury presenting within 48 hours</span><span class="headingEndMark"> — </span>Prostacyclin, a vasodilator, shows promise for the treatment of frostbite. <a class="drug drug_general" data-topicid="8895" href="/z/d/drug information/8895.html" rel="external">Iloprost</a>, a prostacyclin analog (IV formulation not available in the United States), was associated with lower amputation rates among 47 patients treated for severe frostbite compared to those treated with buflomedil in an open label randomized trial [<a href="#rid71">71</a>], and additional case reports of successful treatment with iloprost have been published [<a href="#rid70">70,72</a>].</p><p>We suggest treatment with <a class="drug drug_general" data-topicid="8895" href="/z/d/drug information/8895.html" rel="external">iloprost</a>, with or without tPA, for patients with severe frostbite (Grade 2-4) if given within 48 hours of the initial insult [<a href="#rid73">73</a>]. Iloprost administration may be effective past 48 hours, perhaps up to 72 hours (eg, if a clear history or timeline cannot be established), but supporting data are limited [<a href="#rid74">74</a>]. When used without tPA, administration of iloprost does not require an intensive care setting, nor does it require radiologic intervention. Iloprost should be used alone when tPA is contraindicated, as in frostbite seen more than 24 hours after thawing or in cases associated with trauma. (See <a class="local">'Classification'</a> above and <a class="local">'Clinical manifestations'</a> above.)</p><p><a class="drug drug_general" data-topicid="8895" href="/z/d/drug information/8895.html" rel="external">Iloprost</a> is given by intravenous infusion at a dose 0.5 nanogram/kg per minute, increased every 30 minutes by 0.5 nanogram/kg per minute, to a maximum of 2 nanogram/kg per minute. If the patient develops headache or hypotension, the dose is decreased by 0.5 nanogram/kg per minute. The infusion is given for 6 hours/day for five days at the maximum tolerable rate, up to 2 nanogram/kg per minute [<a href="#rid73">73</a>].</p><p>The use of <a class="drug drug_general" data-topicid="8895" href="/z/d/drug information/8895.html" rel="external">iloprost</a> is safe enough that it can be used in prehospital settings if evacuation to hospital is not feasible [<a href="#rid11">11</a>]. The dosing regimen is the same, but the infusion is stopped after a total of 50 mcg (one vial) has been given, regardless of the weight of the patient. The patient should be evacuated after the first dose, but if this is not practical, the dose can be repeated daily for a total of three days. A single dose is likely beneficial and should be given even if it is not possible to give subsequent doses.</p><p class="headingAnchor" id="H1064844099"><span class="h3">Wound care</span><span class="headingEndMark"> — </span>Subsequent management includes application of a bulky dressing to the affected area, elevation to reduce edema, and daily hydrotherapy to improve range of motion. Splinting may be required to prevent contracture formation.</p><p>The following practices are important in treating these wounds:</p><p class="bulletIndent1"><span class="glyph">●</span>Maintain aseptic technique during wound treatment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Apply nonadherent gauze as the first dressing layer.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use sterile fluff dressing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Insert pledgets (eg, sterile cotton) between digits to prevent tissue maceration during demarcation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Avoid occlusive dressings.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Protect lower extremity wounds with a cradle and upper extremity wounds with sterile sheets.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Keep wounds open immediately following water bath or whirlpool treatment and allow them to dry before applying any dressing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Blisters – There is no clear consensus on management of frostbite-induced blisters. Some authors suggest that because of the high concentrations of inflammatory mediators in the blister fluid, all should be drained. Others take a more conservative approach. A reasonable compromise is to drain, debride, and bandage large nonhemorrhagic bullae that interfere with movement, such as those over joints. Hemorrhagic bullae of comparable size and location are drained by aspiration but are <strong>NOT</strong> debrided. Hemorrhagic bullae reflect more significant damage to the microvasculature. Other minor bullae should be left intact [<a href="#rid8">8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Topical aloe, applied with dressing changes, and oral <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a> (adult dose 400 to 600 mg every 12 hours) or <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> (adult dose 325 mg daily) may limit inflammation associated with frostbite by inhibiting thromboxane and prostaglandins, although supporting evidence is limited [<a href="#rid75">75,76</a>]. In the absence of contraindications, it is reasonable to use these treatments [<a href="#rid77">77</a>].  </p><p></p><p class="headingAnchor" id="H1111318361"><span class="h3">Infection prophylaxis</span></p><p class="bulletIndent1"><span class="glyph">●</span>Tetanus is a reported complication of frostbite. Tetanus prophylaxis is recommended [<a href="#rid78">78</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prophylactic antibiotics are controversial, and little evidence exists to guide decision-making. Post-thaw daily or twice daily warm whirlpool treatments are standard therapy to help to reduce bacterial colonization of injured tissue, but infection can develop nevertheless. We do not recommend routine use of prophylactic antibiotics. We suggest giving parenteral antibiotics at the earliest sign of infection. Staphylococci, streptococci, and pseudomonas species should be covered. Topical antibiotics can cause maceration and should be avoided; if given, antibiotics should be administered intravenously. Appropriate antibiotic selection is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/110530.html" rel="external">"Acute cellulitis and erysipelas in adults: Treatment", section on 'Acute cellulitis'</a>.)</p><p></p><p class="headingAnchor" id="H353541827"><span class="h3">Surgical consultation</span><span class="headingEndMark"> — </span>Because frostbite may require long-term wound care, including hydrotherapy, repeated tissue debridement, escharotomy, fasciotomy, and possibly delayed amputation, we recommend early surgical consultation, preferably with an orthopedic surgeon with experience managing frostbite [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H19125051"><span class="h2">Unproven therapies: Hyperbaric oxygen, pentoxifylline, heparin without thrombolysis, and others</span><span class="headingEndMark"> — </span>Several potential but unproven treatments for frostbite have been reported. Hyperbaric oxygen has been proposed as an adjunctive therapy to improve revascularization and healing of injured tissue. Older studies showed no benefit, but subsequent case reports suggest a possible role and describe improvement in symptoms and the microcirculation of affected tissues [<a href="#rid79">79-81</a>]. A retrospective case series of 22 patients reported no definite improvement in the extent of amputations from hyperbaric oxygen therapy [<a href="#rid82">82</a>]. Further study of hyperbaric treatment is needed before it can be recommended. Hyperbaric oxygen therapy is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/326.html" rel="external">"Hyperbaric oxygen therapy"</a>.)</p><p><a class="drug drug_general" data-topicid="9757" href="/z/d/drug information/9757.html" rel="external">Pentoxifylline</a>, a drug sometimes used to treat claudication, has been proposed as adjunctive therapy for frostbite because of its favorable effect on blood flow [<a href="#rid83">83</a>]. Although the benefit of pentoxifylline in claudication is limited, animal studies of frostbite have had positive results [<a href="#rid84">84,85</a>]. No controlled studies have been performed in humans. Further data are needed before pentoxifylline can be recommended. (See  <a class="medical medical_review" href="/z/d/html/8210.html" rel="external">"Management of claudication due to peripheral artery disease", section on 'Benefit not firmly established'</a>.)</p><p>There is no evidence that intravenous heparin <strong>alone</strong> improves outcomes in frostbite. We do not recommend such treatment. For appropriately selected patients, heparin, or <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">enoxaparin</a>, is given along with thrombolytic therapy. (See <a class="local">'Thrombolysis for severe injury presenting within 24 hours'</a> above.)</p><p class="headingAnchor" id="H12"><span class="h1">COMPLICATIONS</span></p><p class="headingAnchor" id="H692657866"><span class="h2">Overview of short and longer term complications</span><span class="headingEndMark"> — </span>The complications of frostbite are due primarily to peripheral neurovascular injury with associated abnormalities of sympathetic tone. Vasospasm, especially with re-exposure to cold, is common and may be permanent. The severity of complications generally correlates with the severity of the original injury. The sequelae of nonfreezing cold injuries (NFCIs) are similar but often more debilitating than those produced by frostbite [<a href="#rid12">12,86</a>].</p><p>Short-term complications include gangrene and infection of the affected area (<a class="graphic graphic_picture graphicRef101022" href="/z/d/graphic/101022.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef101023" href="/z/d/graphic/101023.html" rel="external">picture 9</a>). Autoamputation may take many weeks to occur. Therapeutic amputation is necessary if deep infection develops before the autoamputation of nonviable tissue. Rarely, acute compartment syndrome may develop and require emergency decompression.</p><p>Throbbing pain that begins two to three days after rewarming may persist for weeks or months, even after nonviable tissue demarcates. Intermittent paresthesias beginning after one week are thought to be due to ischemic neuritis and may last for months. Burning, electric shock sensations may also occur. Hyperhidrosis is common and may be a cause as well as an effect of frostbite.</p><p>Cold exposure is contraindicated for six months after minor injury and for at least 12 months after any significant cold injury. Special precautions to protect previously injured tissue may need to be taken for several years if not indefinitely to prevent further damage. (See <a class="local">'Prevention'</a> below.)</p><p>Longer-term complications include hypersensitivity to the cold; patients remain at increased risk for developing frostbite [<a href="#rid8">8,87</a>]. Late and long-term or permanent sequelae include scarring, tissue atrophy, arthritis, bony abnormalities, and peripheral neuropathy, including hyper or hypoesthesia of digits with decreased proprioception and chronic pain. Pediatric patients may develop necrosis of epiphyses, with devastating growth abnormalities. (See <a class="local">'Complications in children'</a> below.)</p><p class="headingAnchor" id="H2778823917"><span class="h2">Frostbite osteoarthritis</span><span class="headingEndMark"> — </span>Osteoarthritis caused by frostbite occurs most often in the distal extremities. There are numerous case reports of frostbite arthritis of hands in adults, usually not associated with loss of soft tissue. Early changes can include flexion contractures of the proximal interphalangeal joints that may improve over several months or become permanent, sometimes with arthrodesis [<a href="#rid88">88</a>]. Joint swelling may also be permanent and associated with osteo-degenerative changes and juxta-articular swelling of the proximal and distal interphalangeal joints (<a class="graphic graphic_picture graphicRef130505" href="/z/d/graphic/130505.html" rel="external">picture 14</a>) [<a href="#rid89">89-92</a>]. In spite of any deformities, good functional outcomes are common [<a href="#rid88">88,89</a>]. The thumbs are usually spared in frostbite arthritis, in contrast to typical osteoarthritis [<a href="#rid44">44,93</a>].</p><p>Frostbite arthritis of the feet causing flexion contractures of the toes has been reported [<a href="#rid94">94</a>]. Functional outcomes can be good [<a href="#rid95">95</a>] or debilitating [<a href="#rid94">94</a>]. Frostbite arthritis can occur in patients with underlying connective tissue disorders, such as scleroderma or Sjögren's disease, producing a confusing clinical picture, especially if a history of frostbite is not elicited [<a href="#rid96">96</a>].</p><p>Frostbite arthritis has been known for centuries but was first described in modern times in a case series of 100 American soldiers who sustained frostbite injuries, primarily in their feet, while in Korea during 1950 to 1951 [<a href="#rid95">95,97,98</a>]. Transient, mostly mild osteoporosis developed in 58 soldiers. Subsequent changes to the bone consisting of sharply defined, punched out defects, usually near joints, were seen in 7 of 62 soldiers who were observed for at least eight months. There was no correlation between the severity of frostbite and the changes in the joints. Only one soldier had long-term clinical sequelae.</p><p class="headingAnchor" id="H2530056653"><span class="h2">Complications in children</span><span class="headingEndMark"> — </span>Epiphyseal destruction, bone abnormalities, and arthritis are potential sequelae after frostbite of the hands, and occasionally feet, in children [<a href="#rid12">12</a>]. Frostbite need not be severe in order to be associated with damage to the digits. Most reported cases did not involve loss of tissue. Loss of fingernails with subsequent regrowth of normal nails often occurs during the several weeks following injury [<a href="#rid99">99-102</a>]. Multiple nails can be lost with regrowth over months to years [<a href="#rid103">103</a>]. Sometimes, there is sloughing of the epidermis without permanent tissue loss [<a href="#rid99">99,104</a>].</p><p>Bone and joint changes usually begin to become evident several months after frostbite injury. Epiphyseal abnormalities, primarily of the distal and middle phalanges, include partial or complete destruction, fragmentation, and premature fusion (<a class="graphic graphic_picture graphicRef129145" href="/z/d/graphic/129145.html" rel="external">picture 15</a>). Thumbs are seldom affected [<a href="#rid103">103,105,106</a>]. In the affected digits, the distal phalanges and sometimes the middle phalanges are shortened. Proximal phalanges and metacarpals are usually normal. Painful or painless joint swelling may occur 6 to 12 months after the injury [<a href="#rid107">107</a>]. Fingers commonly develop painless flexion deformities of the distal and proximal interphalangeal joints, often with radial deviation of the distal phalanges [<a href="#rid102">102,107</a>] and clinodactyly (curvature of the digits) [<a href="#rid108">108</a>]. Swan neck deformities can also occur [<a href="#rid101">101,108</a>]. Deep frostbite injuries with loss of tissue can cause severe sequelae with markedly limited range of motion of hands or feet [<a href="#rid109">109</a>].</p><p>Frostbite sustained at a young age can result in severe, progressive deformity with decreased range of motion and weakness in extension [<a href="#rid100">100,103,105,106,109,110</a>]. Chronic circulatory changes can include cold intolerance and vasomotor instability [<a href="#rid108">108,111</a>]. Deformities often worsen during growth spurts when affected bones fail to grow while unaffected bones develop normally [<a href="#rid112">112</a>]. When patients reach adulthood, radiographs show less specific changes of chronic arthritis with short phalanges [<a href="#rid103">103</a>]. Their hands often have limited dexterity, which can interfere with fine motor skills such as dressing and using a keyboard [<a href="#rid103">103</a>].</p><p>There are no specific data to guide treatment of frostbite in children. We recommend treating frostbite in children as for adults. There is no treatment proven to prevent permanent sequelae affecting bones and joints. In the largest published case series (13 patients seen 4 to 50 years after frostbite), none sought surgery to improve function or appearance due to chronic disability [<a href="#rid103">103</a>].</p><p class="headingAnchor" id="H13"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Prevention of frostbite includes minimizing predisposing factors, paying attention to weather forecasts, dressing appropriately for the weather, and having an emergency plan when venturing to remote regions [<a href="#rid16">16,17</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Alcohol consumption and smoking should be avoided, as should exposure to water or metal surfaces.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adequate calorie intake and hydration should be maintained.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Predicted high and low temperatures should be noted, as well as forecasted precipitation and wind chill index. In the setting of extreme cold temperature and high winds, frostbite can develop in a matter of minutes [<a href="#rid113">113</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Suggested clothing includes a hat, face protection, eye protection under extreme conditions, mittens (as opposed to gloves), warm and water-resistant shoes, and several layers of loose-fitting clothes. The innermost layer should be a wicking material, such as polypropylene, that will draw moisture away from the skin. The next layer should be of an insulating material such as fleece or wool. The outer-most layer should provide protection against wind, rain, and snow. Wet clothing should be changed as soon as is feasible [<a href="#rid41">41</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Small chemical heat packs may be placed in gloves or shoes but should be used with caution to avoid burns through direct contact with the skin. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The practice of applying emollients to exposed skin to prevent frostbite is widespread in many cold regions of the world. However, literature supporting this practice is lacking. In fact, there is some evidence that this may give the user a false sense of security and increase the risk of frostbite. Therefore, we do not suggest the use of emollients as a preventative measure [<a href="#rid25">25-27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Individuals traveling in remote areas should, prior to departure, inform others of their anticipated route and carry adequate emergency supplies in case they become stranded.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Persons frequently exposed to cold environments should be aware of common frostbite symptoms and signs, and should withdraw to warm shelter when these are noticed.</p><p></p><p class="headingAnchor" id="H691040214"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118151.html" rel="external">"Society guideline links: Management of environmental emergencies"</a>.)</p><p class="headingAnchor" id="H248870645"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/86011.html" rel="external">"Patient education: Frostbite (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification and risk factors</strong> – Risk factors for frostbite or nonfreezing cold injury (NFCI) include anything that increases localized heat loss or decreases heat production. Examples include increased convective heat loss due to exposure to wind or conductive heat loss due to contact with metal or water. Exhaustion, dehydration, malnutrition, alcohol abuse, or comorbidities such as peripheral vascular disease, diabetes, or mental illness also increase risk. The classification of frostbite and other risk factors are discussed in the text. (See <a class="local">'Classification'</a> above and <a class="local">'Risk factors'</a> above and <a class="local">'Definitions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – The areas most frequently affected by frostbite include the ears, nose, cheeks, chin, fingers, and toes. Patients often complain of cold, numbness, and clumsiness of the affected area. The skin may be insensate, white or grayish-yellow in color, and hard or waxy to touch. Bullae containing clear or hemorrhagic fluid may form after thawing. (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging</strong> – Technetium-99m scintigraphy (bone scan) can be used to predict long-term viability of affected tissue and help guide decisions about thrombolytic therapy. Other imaging methods (eg, fluorescence microangiography; magnetic resonance angiography) may also be useful for this purpose, but evidence is limited. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial care and rewarming</strong> – Prehospital and hospital care of frostbite is described in detail in the text. Rapid rewarming, meticulous sterile wound care, possible thrombolysis, and early surgical consultation are key interventions. Rewarming is most effectively accomplished by immersing the affected area in a water bath heated to 37 to 39°C. Such water feels warm but not hot to an unaffected hand. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1">Tetanus prophylaxis and early, aggressive treatment of possible infection should be provided. Prophylactic antibiotics are not routinely recommended. (See <a class="local">'Infection prophylaxis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thrombolysis and anticoagulation therapy</strong> – In patients at high risk for life-altering amputation (eg, multiple digits in a limb, multiple limbs, proximal amputation), <strong>without contraindications</strong> to the use of tissue plasminogen activator (tPA) (<a class="graphic graphic_table graphicRef95035" href="/z/d/graphic/95035.html" rel="external">table 2</a>), who present within 24 hours of injury, we suggest treatment with intravenous (IV) tPA plus heparin (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Treatment with intra-arterial tPA and intra-arterial heparin is also reasonable in hospitals that prefer this approach. If intravenous tPA is used, subcutaneous low molecular weight heparin (eg, <a class="drug drug_general" data-topicid="9407" href="/z/d/drug information/9407.html" rel="external">enoxaparin</a>) may be administered instead of IV heparin.</p><p></p><p class="bulletIndent1">Whenever possible, treatment should be performed at or in consultation with a center experienced in the use of tPA for frostbite. Clinicians must discuss the relative risks and benefits of thrombolytic treatment with the patient and obtain informed consent. Treatment with thrombolytics assumes the patient is willing to accept a small risk of potentially catastrophic bleeding in return for a greater likelihood of retaining functional digits or limbs. Dosing regimens are provided in the text. (See <a class="local">'Thrombolysis for severe injury presenting within 24 hours'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prostacyclin therapy</strong> – For patients who present with significant frostbite (Grades 2 to 4) within 48 hours of the initial insult, we suggest treatment with <a class="drug drug_general" data-topicid="8895" href="/z/d/drug information/8895.html" rel="external">iloprost</a>, a synthetic form of prostacyclin (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). Iloprost is given by intravenous infusion at a dose 0.5 nanogram/kg per minute, increased every 30 minutes by 0.5 nanogram/kg per minute, to a maximum of 2 nanogram/kg per minute. If the patient develops headache or hypotension, the dose is decreased by 0.5 nanogram/kg per minute. The infusion is given for 6 hours/day for five days at the maximum tolerable rate, up to 2 nanogram/kg per minute. (See <a class="local">'Prostacyclin therapy for severe injury presenting within 48 hours'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Strategies for prevention of frostbite are discussed in the text. (See <a class="local">'Prevention'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kroeger K, Janssen S, Niebel W. Frostbite in a mountaineer. Vasa 2004; 33:173.</a></li><li><a class="nounderline abstract_t">Küpper T, Steffgen J, Jansing P. Cold exposure during helicopter rescue operations in the Western Alps. Ann Occup Hyg 2003; 47:7.</a></li><li><a class="nounderline abstract_t">Petrone P, Kuncir EJ, Asensio JA. Surgical management and strategies in the treatment of hypothermia and cold injury. Emerg Med Clin North Am 2003; 21:1165.</a></li><li><a class="nounderline abstract_t">Cattermole TJ. The epidemiology of cold injury in Antarctica. Aviat Space Environ Med 1999; 70:135.</a></li><li><a class="nounderline abstract_t">Simon TD, Soep JB, Hollister JR. Pernio in pediatrics. Pediatrics 2005; 116:e472.</a></li><li><a class="nounderline abstract_t">Atenstaedt RL. Trench foot: the medical response in the first World War 1914-18. Wilderness Environ Med 2006; 17:282.</a></li><li><a class="nounderline abstract_t">Long WB 3rd, Edlich RF, Winters KL, Britt LD. Cold injuries. J Long Term Eff Med Implants 2005; 15:67.</a></li><li><a class="nounderline abstract_t">Murphy JV, Banwell PE, Roberts AH, McGrouther DA. Frostbite: pathogenesis and treatment. J Trauma 2000; 48:171.</a></li><li><a class="nounderline abstract_t">Bhatnagar A, Sarker BB, Sawroop K, et al. Diagnosis, characterisation and evaluation of treatment response of frostbite using pertechnetate scintigraphy: a prospective study. Eur J Nucl Med Mol Imaging 2002; 29:170.</a></li><li><a class="nounderline abstract_t">Cauchy E, Chetaille E, Marchand V, Marsigny B. Retrospective study of 70 cases of severe frostbite lesions: a proposed new classification scheme. Wilderness Environ Med 2001; 12:248.</a></li><li><a class="nounderline abstract_t">Cauchy E, Davis CB, Pasquier M, et al. A New Proposal for Management of Severe Frostbite in the Austere Environment. Wilderness Environ Med 2016; 27:92.</a></li><li class="breakAll">Mills W. Clinical aspects of freezing cold injuries. In: Medical Aspects of Harsh Environments, Pandolf K, Burr R (Eds), Office of the Surgeon General, Falls Church 2001. p.429.</li><li><a class="nounderline abstract_t">Carceller A, Javierre C, Ríos M, Viscor G. Amputation Risk Factors in Severely Frostbitten Patients. Int J Environ Res Public Health 2019; 16.</a></li><li><a class="nounderline abstract_t">Nygaard RM, Whitley AB, Fey RM, Wagner AL. The Hennepin Score: Quantification of Frostbite Management Efficacy. J Burn Care Res 2016; 37:e317.</a></li><li><a class="nounderline abstract_t">Geng Q, Holmér I, Hartog DE, et al. Temperature limit values for touching cold surfaces with the fingertip. Ann Occup Hyg 2006; 50:851.</a></li><li><a class="nounderline abstract_t">Rintamäki H. Predisposing factors and prevention of frostbite. Int J Circumpolar Health 2000; 59:114.</a></li><li><a class="nounderline abstract_t">Castellani JW, Young AJ, Ducharme MB, et al. American College of Sports Medicine position stand: prevention of cold injuries during exercise. Med Sci Sports Exerc 2006; 38:2012.</a></li><li><a class="nounderline abstract_t">Hashmi MA, Rashid M, Haleem A, et al. Frostbite: epidemiology at high altitude in the Karakoram mountains. Ann R Coll Surg Engl 1998; 80:91.</a></li><li><a class="nounderline abstract_t">Moore GW, Semple JL. Freezing and frostbite on mount everest: new insights into wind chill and freezing times at extreme altitude. High Alt Med Biol 2011; 12:271.</a></li><li><a class="nounderline abstract_t">McIntosh SE, Opacic M, Freer L, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of frostbite: 2014 update. Wilderness Environ Med 2014; 25:S43.</a></li><li><a class="nounderline abstract_t">ORR KD, FAINER DC. Cold injuries in Korea during winter of 1950-51. Medicine (Baltimore) 1952; 31:177.</a></li><li><a class="nounderline abstract_t">Ervasti O, Juopperi K, Kettunen P, et al. The occurrence of frostbite and its risk factors in young men. Int J Circumpolar Health 2004; 63:71.</a></li><li><a class="nounderline abstract_t">Olsen N. Diagnostic aspects of vibration-induced white finger. Int Arch Occup Environ Health 2002; 75:6.</a></li><li><a class="nounderline abstract_t">Nagarajan S. Update: Cold weather injuries, active and reserve components, U.S. Armed Forces, July 2010-June 2015. MSMR 2015; 22:7.</a></li><li><a class="nounderline abstract_t">Lehmuskallio E. Emollients in the prevention of frostbite. Int J Circumpolar Health 2000; 59:122.</a></li><li><a class="nounderline abstract_t">Lehmuskallio E. Cold protecting ointments and frostbite. A questionnaire study of 830 conscripts in Finland. Acta Derm Venereol 1999; 79:67.</a></li><li><a class="nounderline abstract_t">Lehmuskallio E, Rintamäki H, Anttonen H. Thermal effects of emollients on facial skin in the cold. Acta Derm Venereol 2000; 80:203.</a></li><li><a class="nounderline abstract_t">Lehmuskallio E, Lindholm H, Koskenvuo K, et al. Frostbite of the face and ears: epidemiological study of risk factors in Finnish conscripts. BMJ 1995; 311:1661.</a></li><li><a class="nounderline abstract_t">Graham CA, Stevenson J. Frozen chips: an unusual cause of severe frostbite injury. Br J Sports Med 2000; 34:382.</a></li><li><a class="nounderline abstract_t">Baran KC, van Munster IG, Vries AM, et al. Severe nitrous-oxide frostbite injuries on the rise in The Netherlands; let's raise awareness. Burns 2020; 46:1477.</a></li><li><a class="nounderline abstract_t">Kuspis DA, Krenzelok EP. Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon. J Toxicol Clin Toxicol 1999; 37:873.</a></li><li><a class="nounderline abstract_t">Wegener EE, Barraza KR, Das SK. Severe frostbite caused by Freon gas. South Med J 1991; 84:1143.</a></li><li><a class="nounderline abstract_t">Kurbat RS, Pollack CV Jr. Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med 1998; 16:167.</a></li><li><a class="nounderline abstract_t">Sever C, Kulahci Y, Uygur F, Sahin C. Frostbite injury of the foot from portable fire extinguisher. Dermatol Online J 2009; 15:10.</a></li><li><a class="nounderline abstract_t">Choong WL, Wohlgemut HS, Hallam MJ. Frostbite following cryolipolysis treatment in a beauty salon: a case study. J Wound Care 2017; 26:188.</a></li><li><a class="nounderline abstract_t">Benoit C, Modarressi A. Severe frostbite complication after cryolipolysis: A case report. JPRAS Open 2020; 25:46.</a></li><li><a class="nounderline abstract_t">Daanen HA, van der Struijs NR. Resistance Index of Frostbite as a predictor of cold injury in arctic operations. Aviat Space Environ Med 2005; 76:1119.</a></li><li><a class="nounderline abstract_t">Sullivan-Kwantes W, Moes K, Limmer R, Goodman L. Finger cold-induced vasodilation test does not predict subsequent cold injuries: A lesson from the 2018 Canadian Forces Exercise. Temperature (Austin) 2019; 6:142.</a></li><li><a class="nounderline abstract_t">Norrbrand L, Kölegård R, Keramidas ME, et al. Finger- and toe-temperature responses to local cooling and rewarming have limited predictive value identifying susceptibility to local cold injury-a cohort study in military cadets. Appl Ergon 2020; 82:102964.</a></li><li><a class="nounderline abstract_t">Harirchi I, Arvin A, Vash JH, Zafarmand V. Frostbite: incidence and predisposing factors in mountaineers. Br J Sports Med 2005; 39:898.</a></li><li class="breakAll">Winter Weather Frequently Asked Questions: What is Frostbite? Centers for Disease Control and Prevention. www.bt.cdc.gov/disasters/winter/faq.asp#frostbite (Accessed on September 20, 2007).</li><li><a class="nounderline abstract_t">Reamy BV. Frostbite: review and current concepts. J Am Board Fam Pract 1998; 11:34.</a></li><li><a class="nounderline abstract_t">Millet JD, Brown RK, Levi B, et al. Frostbite: Spectrum of Imaging Findings and Guidelines for Management. Radiographics 2016; 36:2154.</a></li><li><a class="nounderline abstract_t">Kahn JE, Lidove O, Laredo JD, Blétry O. Frostbite arthritis. Ann Rheum Dis 2005; 64:966.</a></li><li><a class="nounderline abstract_t">Bruen KJ, Ballard JR, Morris SE, et al. Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy. Arch Surg 2007; 142:546.</a></li><li><a class="nounderline abstract_t">Gonzaga T, Jenabzadeh K, Anderson CP, et al. Use of Intra-arterial Thrombolytic Therapy for Acute Treatment of Frostbite in 62 Patients with Review of Thrombolytic Therapy in Frostbite. J Burn Care Res 2016; 37:e323.</a></li><li><a class="nounderline abstract_t">Tavri S, Ganguli S, Bryan RG Jr, et al. Catheter-Directed Intraarterial Thrombolysis as Part of a Multidisciplinary Management Protocol of Frostbite Injury. J Vasc Interv Radiol 2016; 27:1228.</a></li><li><a class="nounderline abstract_t">Masters T, Omodt S, Gayken J, et al. Microangiography to Monitor Treatment Outcomes Following Severe Frostbite Injury to the Hands. J Burn Care Res 2018; 39:162.</a></li><li><a class="nounderline abstract_t">Lacey AM, Fey RM, Gayken JR, et al. Microangiography: An Alternative Tool for Assessing Severe Frostbite Injury. J Burn Care Res 2019; 40:566.</a></li><li><a class="nounderline abstract_t">Twomey JA, Peltier GL, Zera RT. An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite. J Trauma 2005; 59:1350.</a></li><li><a class="nounderline abstract_t">Manganaro MS, Millet JD, Brown RK, et al. The utility of bone scintigraphy with SPECT/CT in the evaluation and management of frostbite injuries. Br J Radiol 2019; 92:20180545.</a></li><li><a class="nounderline abstract_t">Nygaard RM, Lacey AM, Lemere A, et al. Time Matters in Severe Frostbite: Assessment of Limb/Digit Salvage on the Individual Patient Level. J Burn Care Res 2017; 38:53.</a></li><li><a class="nounderline abstract_t">Aygit AC, Sarikaya A. Imaging of frostbite injury by technetium-99m-sestamibi scintigraphy: a case report. Foot Ankle Int 2002; 23:56.</a></li><li><a class="nounderline abstract_t">Kraft C, Millet JD, Agarwal S, et al. SPECT/CT in the Evaluation of Frostbite. J Burn Care Res 2017; 38:e227.</a></li><li><a class="nounderline abstract_t">Barker JR, Haws MJ, Brown RE, et al. Magnetic resonance imaging of severe frostbite injuries. Ann Plast Surg 1997; 38:275.</a></li><li><a class="nounderline abstract_t">Biem J, Koehncke N, Classen D, Dosman J. Out of the cold: management of hypothermia and frostbite. CMAJ 2003; 168:305.</a></li><li><a class="nounderline abstract_t">Su CW, Lohman R, Gottlieb LJ. Frostbite of the upper extremity. Hand Clin 2000; 16:235.</a></li><li><a class="nounderline abstract_t">Hutchison RL. Frostbite of the hand. J Hand Surg Am 2014; 39:1863.</a></li><li><a class="nounderline abstract_t">Zafren K. Frostbite: prevention and initial management. High Alt Med Biol 2013; 14:9.</a></li><li><a class="nounderline abstract_t">McIntosh SE, Hamonko M, Freer L, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of frostbite. Wilderness Environ Med 2011; 22:156.</a></li><li><a class="nounderline abstract_t">Jones LM, Coffey RA, Natwa MP, Bailey JK. The use of intravenous tPA for the treatment of severe frostbite. Burns 2017; 43:1088.</a></li><li><a class="nounderline abstract_t">Lee J, Higgins MCSS. What Interventional Radiologists Need to Know About Managing Severe Frostbite: A Meta-Analysis of Thrombolytic Therapy. AJR Am J Roentgenol 2020; 214:930.</a></li><li><a class="nounderline abstract_t">Hickey S, Whitson A, Jones L, et al. Guidelines for Thrombolytic Therapy for Frostbite. J Burn Care Res 2020; 41:176.</a></li><li><a class="nounderline abstract_t">Johnson AR, Jensen HL, Peltier G, DelaCruz E. Efficacy of intravenous tissue plasminogen activator in frostbite patients and presentation of a treatment protocol for frostbite patients. Foot Ankle Spec 2011; 4:344.</a></li><li><a class="nounderline abstract_t">Ibrahim AE, Goverman J, Sarhane KA, et al. The emerging role of tissue plasminogen activator in the management of severe frostbite. J Burn Care Res 2015; 36:e62.</a></li><li><a class="nounderline abstract_t">Paine RE, Turner EN, Kloda D, et al. Protocoled thrombolytic therapy for frostbite improves phalangeal salvage rates. Burns Trauma 2020; 8:tkaa008.</a></li><li><a class="nounderline abstract_t">Lindford A, Valtonen J, Hult M, et al. The evolution of the Helsinki frostbite management protocol. Burns 2017; 43:1455.</a></li><li><a class="nounderline abstract_t">Drinane J, Kotamarti VS, O'Connor C, et al. Thrombolytic Salvage of Threatened Frostbitten Extremities and Digits: A Systematic Review. J Burn Care Res 2019; 40:541.</a></li><li><a class="nounderline abstract_t">Saemi AM, Johnson JM, Morris CS. Treatment of bilateral hand frostbite using transcatheter arterial thrombolysis after papaverine infusion. Cardiovasc Intervent Radiol 2009; 32:1280.</a></li><li><a class="nounderline abstract_t">Poole A, Gauthier J, MacLennan M. Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series. CMAJ Open 2021; 9:E585.</a></li><li><a class="nounderline abstract_t">Cauchy E, Cheguillaume B, Chetaille E. A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite. N Engl J Med 2011; 364:189.</a></li><li><a class="nounderline abstract_t">Poole A, Gauthier J. Treatment of severe frostbite with iloprost in northern Canada. CMAJ 2016; 188:1255.</a></li><li><a class="nounderline abstract_t">Handford C, Buxton P, Russell K, et al. Frostbite: a practical approach to hospital management. Extrem Physiol Med 2014; 3:7.</a></li><li><a class="nounderline abstract_t">Pandey P, Vadlamudi R, Pradhan R, et al. Case Report: Severe Frostbite in Extreme Altitude Climbers-The Kathmandu Iloprost Experience. Wilderness Environ Med 2018; 29:366.</a></li><li><a class="nounderline abstract_t">Imray C, Grieve A, Dhillon S, Caudwell Xtreme Everest Research Group. Cold damage to the extremities: frostbite and non-freezing cold injuries. Postgrad Med J 2009; 85:481.</a></li><li><a class="nounderline abstract_t">Britt LD, Dascombe WH, Rodriguez A. New horizons in management of hypothermia and frostbite injury. Surg Clin North Am 1991; 71:345.</a></li><li><a class="nounderline abstract_t">McCauley RL, Heggers JP, Robson MC. Frostbite. Methods to minimize tissue loss. Postgrad Med 1990; 88:67.</a></li><li><a class="nounderline abstract_t">Chan TY, Smedley FH. Tetanus complicating frostbite. Injury 1990; 21:245.</a></li><li><a class="nounderline abstract_t">Robins M. Early treatment of frostbite with hyperbaric oxygen and pentoxifylline: a case report. Undersea Hyperb Med 2019; 46:521.</a></li><li><a class="nounderline abstract_t">Finderle Z, Cankar K. Delayed treatment of frostbite injury with hyperbaric oxygen therapy: a case report. Aviat Space Environ Med 2002; 73:392.</a></li><li><a class="nounderline abstract_t">Kemper TC, de Jong VM, Anema HA, et al. Frostbite of both first digits of the foot treated with delayed hyperbaric oxygen:a case report and review of literature. Undersea Hyperb Med 2014; 41:65.</a></li><li><a class="nounderline abstract_t">Ghumman A, St Denis-Katz H, Ashton R, et al. Treatment of Frostbite With Hyperbaric Oxygen Therapy: A Single Center's Experience of 22 Cases. Wounds 2019; 31:322.</a></li><li><a class="nounderline abstract_t">Hayes DW Jr, Mandracchia VJ, Considine C, Webb GE. Pentoxifylline. Adjunctive therapy in the treatment of pedal frostbite. Clin Podiatr Med Surg 2000; 17:715.</a></li><li><a class="nounderline abstract_t">Purkayastha SS, Bhaumik G, Chauhan SK, et al. Immediate treatment of frostbite using rapid rewarming in tea decoction followed by combined therapy of pentoxifylline, aspirin &amp; vitamin C. Indian J Med Res 2002; 116:29.</a></li><li><a class="nounderline abstract_t">Miller MB, Koltai PJ. Treatment of experimental frostbite with pentoxifylline and aloe vera cream. Arch Otolaryngol Head Neck Surg 1995; 121:678.</a></li><li class="breakAll">Thomas JR, Oakley HN. Nonfreezing cold injury. In: Medical Aspects of Harsh Environments, Pandolf KB, Burr RE (Eds), Office of the Surgeon General, Falls Church 2001. p.467.</li><li><a class="nounderline abstract_t">Ervasti O, Hassi J, Rintamäki H, et al. Sequelae of moderate finger frostbite as assessed by subjective sensations, clinical signs, and thermophysiological responses. Int J Circumpolar Health 2000; 59:137.</a></li><li><a class="nounderline abstract_t">Welch GS, Gormly PJ, Lamb DW. Frostbite of the hands. Hand 1974; 6:33.</a></li><li><a class="nounderline abstract_t">Turner M, Smith RW. Unusual and memorable. Erosive nodal osteoarthritis after frostbite. Ann Rheum Dis 1998; 57:271.</a></li><li><a class="nounderline abstract_t">Ellis R, Short JG, Simonds BD. Unilateral osteoarthritis of the distal interphalangeal joints following frostbite: a case report. Radiology 1969; 93:857.</a></li><li><a class="nounderline abstract_t">Glick R, Parhami N. Frostbite arthritis. J Rheumatol 1979; 6:456.</a></li><li><a class="nounderline abstract_t">Irsay L, Ungur RA, Borda IM, et al. Frostbite arthropathy - a rare case of osteoarthritis, review of the literature and case presentation. Rom J Morphol Embryol 2019; 60:1337.</a></li><li><a class="nounderline abstract_t">Wang Y, Saad E, Bonife T, Wainapel SF. Frostbite Arthritis. Am J Phys Med Rehabil 2016; 95:e28.</a></li><li><a class="nounderline abstract_t">Annunziato EJ, Pressman MM, Gorecki GA. Frostbite arthritis of the foot. J Foot Surg 1984; 23:116.</a></li><li><a class="nounderline abstract_t">VINSON HA, SCHATZKI R. Roentgenologic bone changes encountered in frostbite, Korea 1950-51. Radiology 1954; 63:685.</a></li><li><a class="nounderline abstract_t">Chalmers IM, Bock GW. Cold injury in 2 patients with connective tissue disease--frostbite arthritis plus. J Rheumatol 2000; 27:2526.</a></li><li><a class="nounderline abstract_t">Buchanan WW. Frostbite arthritis consequence of first papal visit to Scotland? Clin Rheumatol 1987; 6:436.</a></li><li><a class="nounderline abstract_t">BLAIR JR, SCHATZKI R, ORR KD. Sequelae to cold injury in one hundred patients; follow-up study four years after occurrence of cold injury. J Am Med Assoc 1957; 163:1203.</a></li><li><a class="nounderline abstract_t">DREYFUSS JR, GLIMCHER MJ. Epiphyseal injury following frostbite. N Engl J Med 1955; 253:1065.</a></li><li><a class="nounderline abstract_t">Selke AC Jr. Destruction of phalangeal epiphyses by frostbite. Radiology 1969; 93:859.</a></li><li><a class="nounderline abstract_t">Leung AK, Lai PC. Digital deformities from frostbite. Can Med Assoc J 1985; 132:14.</a></li><li><a class="nounderline abstract_t">Nakazato T, Ogino T. Epiphyseal destruction of children's hands after frostbite: a report of two cases. J Hand Surg Am 1986; 11:289.</a></li><li><a class="nounderline abstract_t">Bigelow DR, Ritchie GW. The effects of frostbite in childhood. J Bone Joint Surg Br 1963; 132:14.</a></li><li><a class="nounderline abstract_t">Wenzl JE, Burke EC, Bianco AJ Jr. Epiphyseal destruction from frostbite of the hands. Am J Dis Child 1967; 114:668.</a></li><li><a class="nounderline abstract_t">Reed MH. Growth disturbances in the hands following thermal injuries in children. 2. Frostbite. Can Assoc Radiol J 1988; 39:95.</a></li><li><a class="nounderline abstract_t">Galloway H, Suh JS, Parker S, Griffiths H. Radiologic case study. Late sequelae of frostbite. Orthopedics 1991; 14:191, 198.</a></li><li><a class="nounderline abstract_t">Lindholm A, Nilsson O, Svartholm F. Epiphyseal destruction following frostbite. Report of three cases. Acta Chir Scand 1968; 134:37.</a></li><li><a class="nounderline abstract_t">Carrera GF, Kozin F, McCarty DJ. Arthritis after frostbite injury in children. Arthritis Rheum 1979; 22:1082.</a></li><li><a class="nounderline abstract_t">Crouch C, Smith WL. Long term sequelae of frostbite. Pediatr Radiol 1990; 20:365.</a></li><li><a class="nounderline abstract_t">Brown FE, Spiegel PK, Boyle WE Jr. Digital deformity: an effect of frostbite in children. Pediatrics 1983; 71:955.</a></li><li><a class="nounderline abstract_t">THELANDER HE. Epiphyseal destruction by frostbite. J Pediatr 1950; 36:105, illust.</a></li><li><a class="nounderline abstract_t">Carrera GF, Kozin F, Flaherty L, McCarty DJ. Radiographic changes in the hands following childhood frostbite injury. Skeletal Radiol 1981; 6:33.</a></li><li class="breakAll">NWS Windchill Chart. www.weather.gov/om/windchill (Accessed on September 20, 2007).</li></ol></div><div id="topicVersionRevision">Topic 179 Version 40.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15461071" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Frostbite in a mountaineer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12505902" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Cold exposure during helicopter rescue operations in the Western Alps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14708823" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Surgical management and strategies in the treatment of hypothermia and cold injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10206932" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The epidemiology of cold injury in Antarctica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16140694" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pernio in pediatrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17219792" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Trench foot: the medical response in the first World War 1914-18.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15715518" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Cold injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10647591" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Frostbite: pathogenesis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11926378" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Diagnosis, characterisation and evaluation of treatment response of frostbite using pertechnetate scintigraphy: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11769921" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Retrospective study of 70 cases of severe frostbite lesions: a proposed new classification scheme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26948558" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : A New Proposal for Management of Severe Frostbite in the Austere Environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26948558" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A New Proposal for Management of Severe Frostbite in the Austere Environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30991721" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Amputation Risk Factors in Severely Frostbitten Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26536540" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The Hennepin Score: Quantification of Frostbite Management Efficacy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16777911" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Temperature limit values for touching cold surfaces with the fingertip.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10998828" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Predisposing factors and prevention of frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17095937" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : American College of Sports Medicine position stand: prevention of cold injuries during exercise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9623370" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Frostbite: epidemiology at high altitude in the Karakoram mountains.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21962071" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Freezing and frostbite on mount everest: new insights into wind chill and freezing times at extreme altitude.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25498262" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Wilderness Medical Society practice guidelines for the prevention and treatment of frostbite: 2014 update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14940410" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cold injuries in Korea during winter of 1950-51.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15139242" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The occurrence of frostbite and its risk factors in young men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11898878" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Diagnostic aspects of vibration-induced white finger.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26505075" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Update: Cold weather injuries, active and reserve components, U.S. Armed Forces, July 2010-June 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10998829" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Emollients in the prevention of frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10086864" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Cold protecting ointments and frostbite. A questionnaire study of 830 conscripts in Finland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10954213" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Thermal effects of emollients on facial skin in the cold.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8541749" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Frostbite of the face and ears: epidemiological study of risk factors in Finnish conscripts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11049150" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Frozen chips: an unusual cause of severe frostbite injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32534889" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Severe nitrous-oxide frostbite injuries on the rise in The Netherlands; let's raise awareness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10630273" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1891741" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Severe frostbite caused by Freon gas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9543396" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Facial injury and airway threat from inhalant abuse: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19930997" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Frostbite injury of the foot from portable fire extinguisher.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28379099" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Frostbite following cryolipolysis treatment in a beauty salon: a case study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32637531" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Severe frostbite complication after cryolipolysis: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16370261" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Resistance Index of Frostbite as a predictor of cold injury in arctic operations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31286025" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Finger cold-induced vasodilation test does not predict subsequent cold injuries: A lesson from the 2018 Canadian Forces Exercise.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31604187" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Finger- and toe-temperature responses to local cooling and rewarming have limited predictive value identifying susceptibility to local cold injury-a cohort study in military cadets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16306495" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Frostbite: incidence and predisposing factors in mountaineers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16306495" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Frostbite: incidence and predisposing factors in mountaineers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9456445" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Frostbite: review and current concepts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27494386" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Frostbite: Spectrum of Imaging Findings and Guidelines for Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15897318" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Frostbite arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17576891" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25950290" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Use of Intra-arterial Thrombolytic Therapy for Acute Treatment of Frostbite in 62 Patients with Review of Thrombolytic Therapy in Frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27363299" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Catheter-Directed Intraarterial Thrombolysis as Part of a Multidisciplinary Management Protocol of Frostbite Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28328661" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Microangiography to Monitor Treatment Outcomes Following Severe Frostbite Injury to the Hands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31298700" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Microangiography: An Alternative Tool for Assessing Severe Frostbite Injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16394908" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30359097" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The utility of bone scintigraphy with SPECT/CT in the evaluation and management of frostbite injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27606554" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Time Matters in Severe Frostbite: Assessment of Limb/Digit Salvage on the Individual Patient Level.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11822694" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Imaging of frostbite injury by technetium-99m-sestamibi scintigraphy: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27306723" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : SPECT/CT in the Evaluation of Frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9088467" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Magnetic resonance imaging of severe frostbite injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12566336" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Out of the cold: management of hypothermia and frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10791170" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Frostbite of the upper extremity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25154574" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Frostbite of the hand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23537254" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Frostbite: prevention and initial management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21664561" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Wilderness Medical Society practice guidelines for the prevention and treatment of frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28159151" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : The use of intravenous tPA for the treatment of severe frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32023122" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : What Interventional Radiologists Need to Know About Managing Severe Frostbite: A Meta-Analysis of Thrombolytic Therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31899512" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Guidelines for Thrombolytic Therapy for Frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21965579" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Efficacy of intravenous tissue plasminogen activator in frostbite patients and presentation of a treatment protocol for frostbite patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25687362" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The emerging role of tissue plasminogen activator in the management of severe frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32341921" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Protocoled thrombolytic therapy for frostbite improves phalangeal salvage rates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28778759" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The evolution of the Helsinki frostbite management protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31188429" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Thrombolytic Salvage of Threatened Frostbitten Extremities and Digits: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19449067" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Treatment of bilateral hand frostbite using transcatheter arterial thrombolysis after papaverine infusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34021017" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Management of severe frostbite with iloprost, alteplase and heparin: a Yukon case series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21226604" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27044477" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Treatment of severe frostbite with iloprost in northern Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24764516" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Frostbite: a practical approach to hospital management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29887348" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Case Report: Severe Frostbite in Extreme Altitude Climbers-The Kathmandu Iloprost Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19734516" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Cold damage to the extremities: frostbite and non-freezing cold injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2003255" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : New horizons in management of hypothermia and frostbite injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2243830" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Frostbite. Methods to minimize tissue loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2228198" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Tetanus complicating frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31509908" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Early treatment of frostbite with hyperbaric oxygen and pentoxifylline: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11952063" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Delayed treatment of frostbite injury with hyperbaric oxygen therapy: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24649719" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Frostbite of both first digits of the foot treated with delayed hyperbaric oxygen:a case report and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31730511" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Treatment of Frostbite With Hyperbaric Oxygen Therapy: A Single Center's Experience of 22 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11070801" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Pentoxifylline. Adjunctive therapy in the treatment of pedal frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12514975" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Immediate treatment of frostbite using rapid rewarming in tea decoction followed by combined therapy of pentoxifylline, aspirin&amp;vitamin C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7772322" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Treatment of experimental frostbite with pentoxifylline and aloe vera cream.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7772322" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Treatment of experimental frostbite with pentoxifylline and aloe vera cream.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10998831" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Sequelae of moderate finger frostbite as assessed by subjective sensations, clinical signs, and thermophysiological responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4825395" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Frostbite of the hands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9741309" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Unusual and memorable. Erosive nodal osteoarthritis after frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5824240" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Unilateral osteoarthritis of the distal interphalangeal joints following frostbite: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/522094" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Frostbite arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32239114" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Frostbite arthropathy - a rare case of osteoarthritis, review of the literature and case presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26488143" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Frostbite Arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6725857" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Frostbite arthritis of the foot.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13215798" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Roentgenologic bone changes encountered in frostbite, Korea 1950-51.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11036861" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Cold injury in 2 patients with connective tissue disease--frostbite arthritis plus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3327644" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Frostbite arthritis consequence of first papal visit to Scotland?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13415876" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Sequelae to cold injury in one hundred patients; follow-up study four years after occurrence of cold injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13272840" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Epiphyseal injury following frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5824241" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Destruction of phalangeal epiphyses by frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3965056" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Digital deformities from frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3958467" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Epiphyseal destruction of children's hands after frostbite: a report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : The effects of frostbite in childhood</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6060032" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Epiphyseal destruction from frostbite of the hands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2967846" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Growth disturbances in the hands following thermal injuries in children. 2. Frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2008388" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Radiologic case study. Late sequelae of frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5673462" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Epiphyseal destruction following frostbite. Report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/486219" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Arthritis after frostbite injury in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2349021" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Long term sequelae of frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6856409" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Digital deformity: an effect of frostbite in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15402671" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Epiphyseal destruction by frostbite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7466414" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Radiographic changes in the hands following childhood frostbite injury.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
